Use of a new hemicellulose dressing (Veloderm®) for the treatment of split-thickness skin graft donor sites A within-patient controlled study

Abstract A multi-centre, open, within-patient controlled study was performed on 23 adult burnt patients to investigate the effectiveness, safety and tolerability of Veloderm ® in comparison with Algisite M™ and Jaloskin ® in split-thickness skin graft donor site care. The areas dressed with Veloderm ® completely healed within 10–13 days in a significant higher proportion than the other two dressings (47.6% for Veloderm ® versus 26.3% for Algisite M™ and 10% for Jaloskin ® , P ® ( P  = 0.0016). Veloderm ® and Jaloskin ® required very few renewals of the medication during the first week of treatment, while Algisite M™ needed several multiple re-dressings. Veloderm ® was judged better than the other two treatments as far as the acceptability ( P P P ® is a safe and effective dressing for the re-epithelialization of the skin graft donor sites: it showed higher activity than the other two compared dressings.